Cetera Investment Advisers
GPCR icon

Cetera Investment Advisers’s Structure Therapeutics GPCR Stock Holding History

Cetera Investment Advisers’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Sell
6,638
-1,082
-14% -$47.9K ﹤0.01% 4005
2026
Q1 		$372K Buy
7,720
+1,124
+17% +$76.9K ﹤0.01% 3790
2025
Q4 		$459K Buy
+6,596
New +$269K ﹤0.01% 3508

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Cetera Investment Advisers's GPCR Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Structure Therapeutics (GPCR) stake by 14% in Q2 2026, selling an estimated $47.9K and leaving 6,638 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #4005.

Cetera Investment Advisers first reported a position in GPCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $459K in Q4 2025. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Cetera Investment Advisers held 6,638 shares of Structure Therapeutics worth $356K as of Q2 2026.
  • Cetera Investment Advisers sold 1,082 Structure Therapeutics shares in Q2 2026, an estimated $47.9K.
  • Structure Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4005 holding.
  • Cetera Investment Advisers first reported a position in Structure Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Cetera Investment Advisers's Structure Therapeutics position peaked at $459K in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.